...
...

gilead

WHO advises against Gilead’s Remdesivir for all hospitalised Covid-19 patients

Two ampules of Ebola drug Remdesivir are pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany.
Updated on Nov 20, 2020 05:48 am IST

Nations mulling Gilead’s Covid-19 drug should consider trial flop, too: WHO

The U.S. Food and Drug Administration on Thursday approved Gilead’s antiviral drug for treating patients hospitalized with Covid-19, making it the first and only drug approved for the disease in the United States.
Updated on Oct 24, 2020 05:40 pm IST

Covid-19: Gilead’s Remdesivir is first virus drug to get FDA approval

A bottle containing the drug Remdesivir is shown by a health worker at the Institute of Infectology of Kenezy Gyula Teaching Hospital of the University of Debrecen in Debrecen, Hungary.
Updated on Oct 23, 2020 04:22 am IST

Gilead questions WHO study that cast doubts on drug’s Covid-19 benefits

The WHO trial was conducted in 11,266 adult patients in more than 30 countries. The evidence was conclusive, the WHO said.
Published on Oct 16, 2020 02:35 pm IST

Remdesivir, hydroxychloroquine did not cut hospital stay or mortality in Covid-19 patients: WHO

A bottle containing the drug Remdesivir is shown by a health worker at the Institute of Infectology of Kenezy Gyula Teaching Hospital of the University of Debrecen in Debrecen, Hungary on Thursday.
Updated on Oct 16, 2020 08:47 am IST